Changwei Dou
Papers
2
Total Citations
13
H-Index
2
About
Dr. Changwei Dou is a pioneering hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for complex biliary cancers. His major contributions center on evaluating and refining robotic and laparoscopic approaches for hilar cholangiocarcinoma (HCCA) and gallbladder cancer—two notoriously challenging malignancies. In his landmark 2024 study, Dr. Dou conducted a propensity score matching analysis to assess biliary-enteric reconstruction outcomes in robotic radical resection for HCCA, demonstrating that robotic techniques can achieve feasible and high-quality reconstructions despite being a critical, technically demanding step. This work has already garnered 10 citations, underscoring its immediate impact on surgical practice. Additionally, his comparative study on the evolution from laparoscopic to robotic radical resection for gallbladder cancer (3 citations) provides valuable insights into the safety and efficacy of transitioning surgical platforms. Dr. Dou’s research is instrumental in establishing robotic surgery as a viable, potentially superior option for hepatobiliary malignancies, offering patients reduced morbidity and improved outcomes. His meticulous, evidence-based approach positions him as a rising leader in the field, shaping the future of minimally invasive oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2